Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus
Results of the OPTIMUS-5 Study
Francesco Franchi, Fabiana Rollini, Victor Kairouz, Jose Rivas Rios, Andrea Rivas, Malhar Agarwal, Maryuri Briceno, Mustafa Wali, Ahmed Nawaz, Gabriel Silva, Zubair Shaikh, Naji Maaliki, Latonya Been, Jason Piraino, Andres M. Pineda, Siva Suryadevara, Daniel Soffer, Martin M. Zenni, Lisa K. Jennings, Theodore A. Bass and Dominick J. Angiolillo
